U.S. Justice Department pursues antitrust case over shipping container price-fixing scheme

U.S. Justice Department pursues antitrust case over shipping container price-fixing scheme
US targets container cartel

Federal prosecutors are advancing a major antitrust case tied to the global shipping disruptions that intensified during the Covid-19 pandemic. The case targets four container manufacturers and seven executives accused of restricting output, inflating prices and worsening shortages across supply chains that affected U.S. consumers.

Highlights

  • The U.S. Justice Department indicted seven Chinese executives and four major shipping container manufacturers for a price-fixing conspiracy involving about $35 billion in global commerce since November 2019.
  • From 2019 to 2021, standard shipping container prices more than doubled, with one company swinging from a $110 million loss to a $180 million profit and another from about $20 million to about $1.75 billion in profit.
  • Prosecutors allege the cartel's quota system and supply restrictions exacerbated U.S. supply chain pressures, boosting costs for American businesses and consumers during the pandemic.

Indictment details and enforcement action

As reported by the U.S. Department of Justice, Acting Assistant Attorney General Omeed A. Assefi says an indictment unsealed today charges seven Chinese executives and four of the world’s largest shipping container manufacturers with violating Section 1 of the Sherman Antitrust Act. One defendant, executive Vick Ma, was arrested earlier in 2026 in France and is awaiting extradition to the United States.

The Justice Department describes the case as involving about $35 billion in global commerce. Prosecutors allege the companies and executives conspired from November 2019 to restrict production of standard shipping containers, creating an artificial shortage that allowed them to raise prices as demand for goods surged during the pandemic.

According to the allegations outlined in the indictment, the six largest Chinese manufacturers control about 95% of the global market for standard unrefrigerated steel containers. Prosecutors say the group monitored compliance with agreed quotas, including by installing video surveillance in each other’s factories and imposing penalties on participants that exceeded output limits.

Assefi says a grand jury returned the indictment in October 2025 and that it remained under seal while authorities pursued arrests. He describes Ma’s detention at Charles de Gaulle airport in Paris on April 14, 2026, as a breakthrough in efforts to hold overseas executives accountable in international cartel cases.

Supply chain and market impact in the U.S.

Prosecutors say the alleged conspiracy intensified pressure on supply chains at a time when U.S. households were already facing shortages of medical supplies, toiletries, home office equipment and other essential goods. The Justice Department argues that by choking container supply, the defendants made it harder and more expensive for goods to reach American businesses and consumers.

From 2019 to 2021, the price of a standard shipping container more than doubled, according to the remarks. The department also points to sharp profit increases at some defendants, including one company that moved from a $110 million loss in 2019 to more than $180 million in profit in 2021, and another whose profit rose from about $20 million to about $1.75 billion over the same period.

The case underscores Washington’s broader focus on economic security, supply chain resilience and criminal antitrust enforcement with cross-border reach. U.S. officials say they will continue pursuing companies and executives accused of manipulating markets that directly affect prices and product availability for American consumers.

Our earlier coverage of the Justice Department’s antitrust priorities in healthcare outlined how officials are directing enforcement toward conduct that can most directly raise household costs, with a focus on improving competition, consumer choice, and affordability. The article highlighted concerns around rising health insurance expenses and the reliability of drug supply, framing these issues within a broader push to target anti-competitive behavior in essential sectors.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.